2.76
price down icon0.36%   -0.01
after-market 시간 외 거래: 2.76
loading
전일 마감가:
$2.77
열려 있는:
$2.81
하루 거래량:
64,967
Relative Volume:
1.12
시가총액:
$37.21M
수익:
-
순이익/손실:
$-13.59M
주가수익비율:
-0.0772
EPS:
-35.74
순현금흐름:
$-19.79M
1주 성능:
+1.10%
1개월 성능:
-20.00%
6개월 성능:
-46.92%
1년 성능:
-10.04%
1일 변동 폭
Value
$2.76
$2.89
1주일 범위
Value
$2.6702
$2.90
52주 변동 폭
Value
$2.05
$8.38

Calcimedica Inc Stock (CALC) Company Profile

Name
명칭
Calcimedica Inc
Name
전화
858-952-5500
Name
주소
505 COAST BOULEVARD SOUTH, LA JOLLA
Name
직원
13
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
CALC's Discussions on Twitter

CALC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CALC
Calcimedica Inc
2.76 37.21M 0 -13.59M -19.79M -1.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Calcimedica Inc 주식(CALC)의 최신 뉴스

pulisher
Dec 19, 2024

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - The Eastern Progress Online

Dec 19, 2024
pulisher
Dec 14, 2024

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - The Eastern Progress Online

Dec 14, 2024
pulisher
Dec 12, 2024

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Eastern Progress Online

Dec 12, 2024
pulisher
Dec 11, 2024

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 07, 2024

Graybug Vision stock hits 52-week low at $2.65 amid market challenges - Investing.com Canada

Dec 07, 2024
pulisher
Dec 06, 2024

CalciMedica director Fred Middleton buys $12,720 in stock By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 06, 2024

CalciMedica director Fred Middleton buys $12,720 in stock - Investing.com

Dec 06, 2024
pulisher
Nov 25, 2024

Atria Investments Inc Purchases 15,296 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Nov 25, 2024
pulisher
Nov 21, 2024

CalciMedica to Present CRAC Channel Therapy Updates at Piper Sandler Healthcare Conference | CALC Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 20, 2024

CalciMedica Announces Presentations at Upcoming Medical Meetings - PR Newswire

Nov 20, 2024
pulisher
Nov 20, 2024

Insiders Bet Big on These Small Cap Stocks - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

CalciMedica Launches $10M+ Public Stock Offering BIOPHARMA: Propelling Calcium-Based Drug Platform By JENNIFER KASTNER - San Diego Business Journal

Nov 19, 2024
pulisher
Nov 18, 2024

CalciMedica’s (CALC) “Buy” Rating Reiterated at HC Wainwright - Defense World

Nov 18, 2024
pulisher
Nov 13, 2024

CalciMedica reports Q3 EPS (50c), consensus (50c) - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

CalciMedica's Auxora Shows 100% Risk Reduction in Respiratory Failure, Extends Cash Runway | CALC Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates - PR Newswire

Nov 13, 2024
pulisher
Nov 08, 2024

CalciMedica Appoints Stephen Bardin as New CFO - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

CalciMedica Appoints Chief Financial Officer - Contract Pharma

Nov 07, 2024
pulisher
Nov 07, 2024

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer - Citizentribune

Nov 07, 2024
pulisher
Nov 06, 2024

CalciMedica director Fred Middleton acquires shares valued at $404,040 - Investing.com India

Nov 06, 2024
pulisher
Nov 06, 2024

CalciMedica director Fred Middleton acquires shares valued at $404,040 By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 06, 2024

CalciMedica sees significant stock purchase by Sanderling Ventures - Investing.com India

Nov 06, 2024
pulisher
Nov 05, 2024

H.C. Wainwright cuts CalciMedica stock target to $16, keeps Buy rating - Investing.com Australia

Nov 05, 2024
pulisher
Nov 02, 2024

Graybug Vision Suspends Stock Offering Amid Proposed Public Offering of CalciMedica - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

Calcimedica director Robert Wilson acquires $199,998 in stock - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica CEO Rachel Leheny acquires $75,000 in common stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Calcimedica director Robert Wilson acquires $199,998 in stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Director Robert Wilson Acquires 53,333 Shares of CalciMedica Inc (CALC) - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica CEO Rachel Leheny acquires $75,000 in common stock - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock - Investing.com

Nov 01, 2024
pulisher
Oct 31, 2024

CalciMedica announces proposed public offering of common stock - MSN

Oct 31, 2024
pulisher
Oct 30, 2024

CalciMedica Announces Pricing of Public Offering of Common Stock - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica launches public stock offering - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica launches public stock offering By Investing.com - Investing.com UK

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica Announces Proposed Public Offering of Common Stock - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica, Inc. (NASDAQ:CALC) Sees Significant Decline in Short Interest - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica’s Promising Phase 2b Trial Results for Auxora - TipRanks

Oct 30, 2024

Calcimedica Inc (CALC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):